AGREEMENTSchedule 13d Agreement • August 11th, 2022 • Frazier Life Sciences IX, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of Common Stock of Phathom Pharmaceuticals, Inc.
AGREEMENTSchedule 13d Agreement • March 9th, 2020 • Frazier Life Sciences IX, L.P. • Biological products, (no disgnostic substances)
This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017.
AGREEMENTSchedule 13g Agreement • August 27th, 2018 • Frazier Life Sciences IX, L.P. • Biological products, (no disgnostic substances)
This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017.
AGREEMENTSchedule 13g Agreement • November 6th, 2024 • Frazier Life Sciences IX, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Tarsus Pharmaceuticals, Inc.
AGREEMENTExhibit Agreement • November 6th, 2019 • Frazier Life Sciences IX, L.P. • Pharmaceutical preparations
This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017.
AGREEMENTSchedule 13d Agreement • September 5th, 2023 • Frazier Life Sciences IX, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of Common Stock of Mirum Pharmaceuticals, Inc.
AGREEMENTExhibit Agreement • April 14th, 2023 • Frazier Life Sciences IX, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of Common Stock of Mirum Pharmaceuticals, Inc.
